TCL Archive Neutron Therapy “Treatment Of Choice” In Salivary Gland Tumors – 100 Percent Complete Reponses June 13, 1986
TCL Archive NCI Plans $175 Million In Program Cuts To Cover Deficit, Fund New Initiatives November 17, 2006
TCL Archive Xeloda, Taxotere, Herceptin Combination May Benefit Invasive Breast Cancer January 25, 2008
TCL Archive Chemical Distribution To Grantees Delayed while HEW Considers Charging For It June 22, 1979